Fully vaccinated Americans can discard masks and the need for social distancing outdoors and in most indoors settings, the CDC said Thursday in a dramatic announcement after months of mostly cautious measures.
The new guidelines announced by Dr. Rochelle Walensky, director of the Centers for Disease Control and Prevention, represent a major step toward a return to normalcy for a nation battered and at times divided by a pandemic that has lasted more than a year. Anyone who is fully vaccinated can participate in indoor and outdoor activities, large or small, without wearing a mask or physical distancing, Walensky said. If you are fully vaccinated, you can start doing the things that you had stopped doing because of the pandemic.
COVID: US travel to India restricted; Florida suspends mask orders
thenorthwestern.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thenorthwestern.com Daily Mail and Mail on Sunday newspapers.
Reports of COVID-19 vaccine side effects support what many have anecdotally observed: women shoulder the bigger burden.
Among nearly 7,000 reports processed through the Centers for Disease Control and Prevention s Vaccine Adverse Event Reporting System (VAERS) from Dec. 14 to Jan. 13, more than 79% of them came from women. The most frequently reported side effects were headache, fatigue and dizziness.
Women also are more likely than men to experience some of the vaccine’s more unusual side effects, such as an itchy red rash that appears at the injection site commonly known as COVID arm or Moderna arm, as about 95% of the reactions occur with the Moderna vaccine. Overall, women account for 77% of the Moderna vaccine’s reported side effects.
USA TODAY
An advisory committee voted unanimously Friday to recommend authorizing a COVID-19 vaccine from Johnson & Johnson for use in adults, paving the way for an expected Food and Drug Administration authorization within the next few days.
Johnson & Johnson agreed to provide 100 million doses of its single-shot vaccine in the U.S. by June, including 20 million by the end of March. Those doses will add to the 300 million doses Pfizer-BioNTech and Moderna each have promised to deliver by the end of July.
The vaccine was shown to be 72% effective in a U.S. trial in which all ethnic, racial and age groups benefited about the same, and was shown to be 85% effective in preventing the most severe disease.
An advisory committee voted unanimously Friday to recommend authorizing a COVID-19 vaccine from Johnson & Johnson for use in adults, paving the way for an expected Food and Drug Administration authorization within the next few days.
Johnson & Johnson agreed to provide 100 million doses of its single-shot vaccine in the U.S. by June, including 20 million by the end of March. Those doses will add to the 300 million doses Pfizer-BioNTech and Moderna each have promised to deliver by the end of July.
The vaccine was shown to be 72% effective in a U.S. trial in which all ethnic, racial and age groups benefited about the same, and was shown to be 85% effective in preventing the most severe disease.
vimarsana © 2020. All Rights Reserved.